Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized Non-inferiority Trial of Early Treatment Versus Expectative Management of Patent Ductus Arteriosus in Preterm Infants (BeNeDuctus Trial - Belgium Netherlands Ductus Trial)

NCT02884219 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02884219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02884219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized Non-inferiority Trial of Early Treatment Versus Expectative Management of Patent Ductus Arteriosus in Preterm Infants (BeNeDuctus Trial - Belgium Netherlands Ductus Trial)
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
December 23, 2016
Completion date
March 15, 2022
Enrollment
273 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

patent ductus arteriosus